|
نبذة شخصية:
|
Cycle 3, Randomized Research of Two Human being Epidermal Growth Issue Receptor Only two (HER2) Restriction Together with Sorafenib Plus Trastuzumab in Combination With a great Aromatase Inhibitor within Postmenopausal Women Together with HER2-Positive, Hormone Receptor-Positive Stage 4 cervical cancer: Up-to-date Link between ALTERNATIVE
|